Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36400069

Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2023 Jan
First author
Shadman M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2023 Jan;10(1):e5-e6. doi: 10.1016/S2352-3026(22)00333-7.
    note
    Source null
    related pmid
    36400068
    relationship
    Comment in

Authors and identifiers

  1. name
    Shadman M
    type
    Author
  2. name
    Flinn IW
    type
    Author
  3. name
    Levy MY
    type
    Author
  4. name
    Porter RF
    type
    Author
  5. name
    Burke JM
    type
    Author
  6. name
    Zafar SF
    type
    Author
  7. name
    Misleh J
    type
    Author
  8. name
    Kingsley EC
    type
    Author
  9. name
    Yimer HA
    type
    Author
  10. name
    Freeman B
    type
    Author
  11. name
    Rao SS
    type
    Author
  12. name
    Chaudhry A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Shadman M
    type
    Author
  2. name
    Flinn IW
    type
    Author
  3. name
    Levy MY
    type
    Author
  4. name
    Porter RF
    type
    Author
  5. name
    Burke JM
    type
    Author
  6. name
    Zafar SF
    type
    Author
  7. name
    Misleh J
    type
    Author
  8. name
    Kingsley EC
    type
    Author
  9. name
    Yimer HA
    type
    Author
  10. name
    Freeman B
    type
    Author
  11. name
    Rao SS
    type
    Author
  12. name
    Chaudhry A
    type
    Author
bibliography ids
  1. nci-bib-8828678fb78e4a07118f1d4f
book metadata
content sha256
2695fa5334588dab2f4766a6f5100234afdcc0aa31d4d565e97c1bc97572fa95
document type
citation
dois
  1. 10.1016/S2352-3026(22)00320-9
electronic publication date
display
2022 Nov 16
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36400069
immutable id
pubmed:36400069@2695fa5334588dab2f4766a6f5100234afdcc0aa31d4d565e97c1bc97572fa95
journal
abbreviation
Lancet Haematol
issn electronic
2352-3026
issn print
Source null
issue
1
name
The Lancet. Haematology
nlm unique id
101643584
pages
e35-e45
volume
10
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2023 Jan;10(1):e5-e6. doi: 10.1016/S2352-3026(22)00333-7.
    note
    Source null
    related pmid
    36400068
    relationship
    Comment in
outcomes validated
false
pmid
36400069
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
c678089a81c3218c594f0cea1cfecc6aea31a2b108820b775559d37fdd4b21a6
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Jan
precision
month
year
2023
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36400069/
title
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.

Preserved source evidence · Not medical advice